West Pharmaceutical Services reported $136.6M in Operating Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Align Technology ALGN:US USD 143.66M 44.54M
Atrion ATRI:US USD 11.03M 3.19M
Baxter International BAX:US USD -2799000000 3.15B
Becton, Dickinson and BDX:US USD 490M 45M
Catalent CTLT:US USD 60M 186M
Charles River Laboratories CRL:US USD 150.98M 36.43M
Cooper Companies COO:US USD 140.6M 7.9M
Icu Medical ICUI:US USD -467000 419K
Insulet PODD:US USD 2.9M 29.6M
Integra Lifesciences IART:US USD 63.73M 2.67M
IQVIA Holdings Inc IQV:US USD 472M 19M
Johnson & Johnson JNJ:US USD 5.82B 18M
Medtronic MDT:US USD 1.07B 606M
Meridian Bioscience VIVO:US USD -6681000 42.82M
Merit Medical Systems MMSI:US USD 18.66M 4.6M
Orasure Technologies OSUR:US USD 875K 22.16M
Repligen RGEN:US USD 52.66M 10.5M
Terumo 4543:JP JPY 25.55B 4.88B
West Pharmaceutical Services WST:US USD 136.6M 91.4M